Ya-nan Liu

No ORCID on file · 4 papers in corpus · active 2010-2022

Study types

  • article 4

Condition tags

  • endometriosis 4
  • mesh:D004715 3
  • infertility 1
article 2022
Frontiers in pharmacology ·doi:10.3389/fphar.2022.874973

Relugolix, a gonadotropin-releasing hormone (GnRH) receptor antagonist, has been well studied in the treatment of endometriosis symptomatic. It is mainly metabolized by the CYP3A subfamily of P450 enzymes, while minorly metabolized by CYP2C…

article 2015
Chinese medical journal ·doi:10.4103/0366-6999.151108

BACKGROUND: We investigated possible biomarkers for endometriosis (EM) using the ClinProt technique and proteomics methods. METHODS: We enrolled 50 patients with EM, 34 with benign ovarian neoplasms and 40 healthy volunteers in this study. …

article 2010
Zhonghua fu chan ke za zhi

OBJECTIVE: To investigate the impact on fertility potential of patients with stage I endometriosis treated by gonadotropin-releasing hormone agonist (GnRH-a) treatment followed by laparoscopy surgery. METHODS: From Jan. 2006 to Jun. 2008, m…

article 2010
Zhonghua fu chan ke za zhi

OBJECTIVE: To investigate the value of human epididymis secretory protein 4(HE4) combined with CA125 assay in differential diagnosis of endometriosis cyst and ovarian malignant tumor. METHODS: The level of HE4 and CA125 were measured by enz…